A few comments..
* Bronchitol works higher up the pathological cascade hence could replace the need for Pulmoyze and anti-biotics in some patient groups
* For adults over 6months, FEV1 under control (50ml bronchitol as compartor) is 4.88% improvement vs 4.68% improvement for baseline. I thought it would be 8%+ for adults from baseline?! Lombard et al - whats your take on this?
* ASM8 looks like a good prospect
* I wonder if mgt can put out data for 24months etc I wonder if it shows constant improvement
- Forums
- ASX - By Stock
- SNT
- Ann: Investor Presentation
Ann: Investor Presentation , page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
3.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $45.16M |
Open | High | Low | Value | Volume |
3.5¢ | 3.6¢ | 3.5¢ | $27.92K | 778.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 853533 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.6¢ | 286037 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 0.036 |
4 | 982104 | 0.035 |
5 | 1380166 | 0.034 |
3 | 995000 | 0.033 |
5 | 1256634 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 6 | 1 |
0.036 | 286037 | 1 |
0.037 | 134500 | 1 |
0.038 | 367592 | 2 |
0.039 | 348913 | 2 |
Last trade - 15.57pm 28/08/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online